Amgen

Tezspire

  1. Home
  2.  / 
  3. J Code
  4.  / Tezspire – J2356

Manufacturer:

Amgen

Name:

Tezspire

HCPCS Code Descriptor:

Injection, tezepelumab-ekko, 1 mg

Category:

J Code

HCPCS:

J2356

NDC(s):

55513-0123-01, 55513-0112-01

Primary Type:

Anti-Eosinophil Asthma

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

Tezspire is an Anti-Eosinophil Asthma drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2356 is aligned to the drug Tezspire.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/22

HCPCS Effective Date:

7/1/22

HCPCS Short Description:

Inj tezepelumab-ekko, 1mg

Billing and Coding Guide:

https://www.tezspirehcp.com/content/dam/open-digital/tezspirehcpday1/en/pdf/TEZSPIRE_Billing_and_Coding_Guide.pdf?source=TZP_N_H_2284&umedium=cpc&uadpub=GOOGLE&ucampaign=USA_GO_SEM_HCP_B_PH_Brand-Tezspire&ucreative=Core&uplace=tezspire&outcome=HCP&cmpid=1&cid=PPC-accountype:GOOGLE-campaign:USA_GO_SEM_HCP_B_PH_Brand-Tezspire-searchterm:tezspire-adgroup:Core-keywordid:p68215832627&us_privacy=${us_privacy}&gclsrc=aw.ds&

Patient Assistance:

https://www.tezspire.com/savings-and-support.html